There’s an ongoing push to improve health care affordability and reduce out-of-pocket costs, especially for prescription ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

The Medicare $2 Drug List Model included generic drugs for high blood pressure, diabetes and other ailments many elderly face ...

Adjusted EBITDA margin increased to 37.2% from 25.2% in Q4 2024, driven by cost reductions and operational improvements. Management's tone shifted positively, highlighting stronger-than-expected ...

As a leader in renewable energy resources, Minnesota could have an outsized impact from the climate change-fighting provisions of the Inflation Reduction Act. The bill, signed into law by ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance.

H.A. Roepke has sold his harness shop to Andrew Amundson. Oscar Schirber, who owned an interest in the stock, has withdrawn his portion and Mr. Amundson will conduct the ...

One in five adults in the UK is thought to be living with diabetes or prediabetes, which causes higher than normal blood ...